Lumos Pharma Inc (NASDAQ:LUMO)
| 10.05 Delayed Data As of 3:59pm ET |  -0.13 / -1.28%Today’s Change | 9.53 Today|||52-Week Range 36.72 | -71.86% Year-to-Date |
Latest LUMO News | Press Releases
No recent news for Lumos Pharma Inc.
Today’s Trading
| Previous close | 10.18 |
| Today’s open | 9.98 |
| Day’s range | 9.98 - 10.29 |
| Volume | 433 |
| Average volume (3 months) | 56,038 |
| Market cap | $111.8M |
Data as of 3:59pm ET, 05/11/2021
Growth & Valuation
| Earnings growth (last year) | +91.02% |
| Earnings growth (this year) | -359.29% |
| Earnings growth (next 5 years) | +15.24% |
| Revenue growth (last year) | -82.05% |
| P/E ratio | NM |
| Price/Sales | 1,440.71 |
| Price/Book | 0.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZSANZosano Pharma Corp | -0.03 | -3.65% |
| SLNOSoleno Therapeutics ... | -0.04 | -3.24% |
| PRPHProphase Labs Inc | -0.20 | -3.51% |
| APMAptorum Group Ltd | +0.10 | +3.89% |
Data as of 3:59pm ET, 05/11/2021
Financials
| Next reporting date | August 19, 2021 |
| EPS forecast (this quarter) | -$1.04 |
| Annual revenue (last year) | $168.0K |
| Annual profit (last year) | -$6.3M |
| Net profit margin | -3,758.33% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
